Urteste S.A. Logo

Urteste S.A.

Develops non-invasive urine tests to detect cancers early by measuring enzyme activity.

URT | WAR

Overview

Corporate Details

ISIN(s):
PLURTST00010 (+1 more)
LEI:
259400Q4S6JIKFQHGU06
Country:
Poland
Address:
Gdańsk Starodworska 1, 80-137 Gdańsk
Sector:
Mining and quarrying
Industry:
Mining of non-ferrous metal ores

Description

Urteste S.A. is a research and development company specializing in innovative in vitro diagnostic (IVD) medical devices. The company focuses on creating a pioneering technology for the early detection of multiple types of cancer from a single, non-invasive urine sample. Its proprietary method is based on measuring the activity of specific enzymes to identify malignancies at an early stage, with the goal of substantially increasing patient survival rates. The company's development pipeline includes diagnostic tests for various cancers, such as the Panuri Test for pancreatic cancer and a test for breast cancer.

Social Media

Unlock This Filing & Millions More

You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.

Filings

You have of free filing views remaining. Upgrade for unlimited access.
Quick Filters:

Filters

Clear
Bulk Actions:
Date Filing Language Size Actions
2025-11-07 16:00
Share Issue/Capital Change
OPINIA ZARZĄDU uzasadniająca powody pozbawienia akcjonariuszy prawa poboru akcji
Polish 178.5 KB
2025-11-07 16:00
Post-Annual General Meeting Information
Projekty uchwał
Polish 229.9 KB
2025-11-07 16:00
Proxy Solicitation & Information Statement
Pełnomocnictwo udzielane przez osoby prawne do uczestnictwa
Polish 160.7 KB
2025-11-07 16:00
Regulatory News Service
Pełnomocnictwo udzielane przez osoby fizyczne do uczestnictwa
Polish 156.4 KB
2025-11-07 16:00
Regulatory News Service
INFORMACJE DOTYCZĄCE PRZETWARZANIA DANYCH OSOBOWYCH AKCJONARIUSZY I PEŁNOMOCNIK…
Polish 191.5 KB
2025-11-07 16:00
Declaration of Voting Results & Voting Rights Announcements
INFORMACJA o ogólnej liczbie akcji w Spółce Urteste S.A.
Polish 118.9 KB
2025-11-07 16:00
Regulatory News Service
FORMULARZ pozwalający na wykonywanie prawa głosu przez pełnomocnika
Polish 284.9 KB
2025-11-07 16:00
Pre-Annual General Meeting Information
Ogłoszenie Zarządu Urteste S.A.
Polish 217.3 KB
2025-11-07 16:00
Pre-Annual General Meeting Information
Zwołanie Nadzwyczajnego Walnego Zgromadzenia na dzień 4 grudnia 2025 roku - Con…
Polish 1.5 KB
2025-11-07 10:36
Share Issue/Capital Change
Zawarcie dwóch umów inwestycyjnych dotyczących dokapitalizowania Spółki - Conte…
Polish 2.6 KB
2025-10-31 10:46
Legal Proceedings Report
Zawarcie umowy z firmą typu CRO - rozpoczęcie wieloośrodkowego badania kliniczn…
Polish 3.2 KB
2025-10-20 17:09
Capital/Financing Update
Zawarcie umowy pożyczki - Content (PL)
Polish 1.4 KB
2025-09-29 17:38
Audit Report / Information
Opinia biegłego
Polish 366.5 KB
2025-09-29 17:38
Management Discussion and Analysis
Sprawozdanie z działalności Zarządu za I półrocze 2025
Polish 1.0 MB
2025-09-29 17:38
Interim Report
Sprawozdanie finansowe za I półrocze 2025
Polish 1.2 MB

Automate Your Workflow. Get a real-time feed of all Urteste S.A. filings delivered via API.

Explore Data Feeds →

Market Data

Market Data Not Available

Financials & KPIs

No data available

Unlock Full Financials for Urteste S.A.

This data is available as part of our premium data solutions. Contact our team for access.

Need More History? Access decades of standardized financials for Urteste S.A. via our API.

Get Historical Data →

Insider Transactions

Date Insider Name Position Type Shares Value
No insider transactions recorded for this company.

Peer Companies

Acrivon Therapeutics, Inc. Logo
Develops precision cancer therapies by matching patients to drugs using its proteomics platform.
United States of America
ACRV
Acticor Biotech Logo
Clinical-stage biopharma developing a first-in-class drug for thrombotic diseases like stroke.
France
ALACT
Acumen Pharmaceuticals, Inc. Logo
Clinical-stage biopharma developing an antibody therapy for Alzheimer's by targeting toxic AβOs.
United States of America
ABOS
Adaptive Biotechnologies Corp Logo
Maps immune genetics for blood cancer diagnostics and drug discovery partnerships.
United States of America
ADPT
Adecco Group AG Logo
Global talent solutions firm offering staffing, placement, career transition, and tech consulting.
Switzerland
ADI1
Adeia Inc. Logo
Invents and licenses foundational IP for the media and semiconductor industries.
United States of America
ADEA
ADforus Co., Ltd. Logo
Ad-tech firm with AI platforms for mobile marketing and publisher monetization solutions.
South Korea
397810
Aditxt, Inc. Logo
Acquires and develops biotech for autoimmunity, cancer detection, and neuro diagnostics.
United States of America
ADTX
Adocia Logo
Biotech improving protein drug formulations for diabetes & obesity and developing cell therapies.
France
ADOC
ad pepper media International N.V. Logo
Global performance marketing & audience targeting solutions for advertisers and agencies worldwide.
Germany
APM

Talk to a Data Expert

Have a question? We'll get back to you promptly.